Related Experiment Video
Updated: Sep 12, 2025

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
Published on: September 28, 2019
Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment
Anaïs Choquet1, Aurélien Sokal2, Safi Dokmak1
1Department of HPB Surgery, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.
Recurrent nonobstructive cholangitis (RNOC) affects 8% of patients after pancreaticoduodenectomy (PD). Noninvasive intraductal papillary mucinous neoplasm (IPMN) is the primary risk factor for RNOC, and revision surgery shows limited benefit.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Hepatobiliary Surgery
Background:
- Recurrent nonobstructive cholangitis (RNOC) is a delayed complication following pancreaticoduodenectomy (PD).
- Differentiating RNOC from obstructive cholangitis is crucial.
- Risk factors for RNOC remain poorly understood.
Purpose of the Study:
- To determine the prevalence of RNOC after PD.
- To identify risk factors associated with RNOC development.
- To describe the management strategies and outcomes for RNOC.
Main Methods:
- A case-control study analyzed 320 patients from a prospective database (2014-2018) who underwent PD.
- Patients with less than 1-year follow-up or early complications were excluded.
- RNOC was defined as ≥3 cholangitis episodes >1 year post-PD without other causes; risk factors were identified via univariate and multivariate analyses.
Main Results:
- 8% (27/320) of patients developed RNOC with a median follow-up of 47 months.
- Noninvasive intraductal papillary mucinous neoplasm (IPMN) was the sole independent risk factor for RNOC (OR=3.222, p=0.018).
- Most patients received antibiotics; 11% experienced complications (hepatic abscesses, organ failure), and revision surgery was ineffective in two cases.
Conclusions:
- RNOC is an 8% complication rate following PD.
- Noninvasive IPMN is a significant risk factor for RNOC.
- Surgical revision to lengthen the biliary loop appears to have limited efficacy in preventing RNOC recurrence.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Endoscopic Procedures V: ERCP
Patient...
